Acelrx Pharmaceuticals reported $-8995000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8995000 820K
Acura Pharmaceuticals ACUR:US -300000 154K
Baxter International BAX:US $ 163M 183M
Becton, Dickinson and BDX:US $ 652M 163M
Cara Therapeutics CARA:US $ -27911000 5.61M
Heron Therapeutics HRTX:US $ -62.92M 9.39M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
Johnson & Johnson JNJ:US $ 5862M 1026M
Pain Therapeutics PTIE:US $ -17821000 3.38M
Pfizer PFE:US $ 9873M 5297M
Smiths SMIN:LN 157M 26M
Teva Pharmaceutical TEVA:IT -713000000 791M
Xeris Pharmaceuticals Inc XERS:US $ -29074000 19.2M